References
- Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie T-X, Zhang J, Wang J, et al. 2011. Exome sequencing of headand neck squamous cell carcinoma reveals inactivating mutations inNOTCH1. Science. 6046:1154–1157. doi: https://doi.org/10.1126/science.1206923
- Alyasiri NS, Mehdi SJ, Alam MS, Ali A, Mandal AK, Gupta S, Singh I, Rizvi MM. 2012. PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients. J Cancer Res Clin Oncol. 138(1):103–109. doi: https://doi.org/10.1007/s00432-011-1077-y
- Babiker AY, Almatroudi A, Allemailem KS, Husain NEOS, Alsammani MA, Alsahli MA, Rahmani AH. 2018. Clinicopathologic aspects of squamous cell carcinoma of the uterine cervix: role of PTEN, BCL2 and P53. Appl. Sci. 8:2124. doi: https://doi.org/10.3390/app8112124
- Ben-Izhak O, Laster Z, Akrish S, Cohen G. 2008. Nagler RM: TUNEL as a tumor marker of tongue cancer. Anticancer Res. 28:2981–2986.
- Brazil DP, Yang ZZ, Hemmings BA. 2004. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci. 29(5):233–242. doi: https://doi.org/10.1016/j.tibs.2004.03.006
- Camisasca DR, Honorato J, Bernardo V, da Silva LE, da Fonseca EC, de Faria PA, Dias FL. 2009. Lourenco SQ: expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma. Oral Oncol. 45:225–233. doi: https://doi.org/10.1016/j.oraloncology.2008.05.021
- Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 6(4):389–395. doi: https://doi.org/10.1038/74651
- Carmeliet P, Jain RK. 2000. Angiogenesis in cancer and other diseases. Nature. 407:249–257. doi: https://doi.org/10.1038/35025220
- Cheng D, Liang B, Li Y. 2013. Serum vascular endothelial growth factor (VEGF-C) as a diagnostic and prognostic marker in patients with ovarian cancer. PLoS One. 8:e55309. doi: https://doi.org/10.1371/journal.pone.0055309
- Cheung M, Testa JR. 2013. Diverse mechanisms of AKT pathway activation in human malignancy. Curr Cancer Drug Targets. 13(3):234-244. doi: https://doi.org/10.2174/1568009611313030002
- Conway DI, Hashibe M, Boffetta P, Wunsch-Filho V, Muscat J, La Vecchia C, Winn DM. 2009. Enhancing epidemiologic research on head and neck cancer: INHANCE – The international head and neck cancer epidemiology consortium. Oral Oncol. 45:743–746. doi: https://doi.org/10.1016/j.oraloncology.2009.02.007
- Courtney KD, Corcoran RB, Engelman JA. 2010. The PI3K pathway as drug target in human cancer. J ClinOncol. 28( ):1075–1083. doi: https://doi.org/10.1200/JCO.2009.25.3641
- Ferrara N. 2001. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol. 280:C1358–C1366. doi: https://doi.org/10.1152/ajpcell.2001.280.6.C1358
- Gasinska A, Fowler JF, Lind BK. 2004. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone. ActaOncol. 43:657–666.
- Gavrieli Y, Sherman Y, Ben-Sasson SA. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493–501. doi: https://doi.org/10.1083/jcb.119.3.493
- Gkiozos I, Tsagouli S, Charpidou A, Grapsa D, Kainis E, Gratziou C, Syrigos K. 2015. Levels of vascular endothelial growth factor in serum and pleural fluid are independent predictors of survival in advanced non-small cell lung cancer: results of a prospective study. Anticancer Res. 35:1129–1137.
- Hasina R, Lingen MW. 2001. Angiogenesis in oral cancer. J Dent Educ. 65:1282–1290. doi: https://doi.org/10.1002/j.0022-0337.2001.65.11.tb03489.x
- Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. 2005. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 4(12):988–1004. doi: https://doi.org/10.1038/nrd1902
- Hockenbery DM. 1994. Bcl-2 in cancer, development and apoptosis. J Cell Sci. 18:51–55. doi: https://doi.org/10.1242/jcs.1994.Supplement_18.7
- Hou X, Wei JC, Fu JH, Wang X, Luo RZ, He JH, Zhang LJ, Lin P, Yang HX. 2015. Vascular endothelial growth factor is a Useful Predictor of Postoperative Distant metastasis and survival prognosis in Esophageal squamous cell carcinoma. Ann SurgOncol. 22:3666–3673.
- Kim S-K, Park S-G, Kim K-W. 2015 Feb. Expression of vascular endothelial growth factor in oral squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg. 41(1):11–18. doi: https://doi.org/10.5125/jkaoms.2015.41.1.11
- Kumar A, Purohit R. 2013. Cancer associated E17K mutation causes rapid conformational drift in AKT1 Pleckstrin Homology (PH) Domain. PLoS ONE. 8(5). Article ID e64364. doi: https://doi.org/10.1371/annotation/7c19edf3-4648-45de-8132-16092fc4bf40
- Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ. 2005. Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol. 131(9):624–630. doi: https://doi.org/10.1007/s00432-005-0003-6
- Lamaroon A, Krisanaprakornkit S. 2009. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma. Oral Oncol. 45:e175–e179. doi: https://doi.org/10.1016/j.oraloncology.2009.06.003
- Lim J, Kim J-H, Paeng J-Y, Kim M-J, Hong S-D, Lee J-I, Hong S-P. 2005 Nov. Prognostic value of activated Akt expression in oral squamous cell carcinoma. J ClinPathol. 58(11):1199–1205.
- Lockshin RA, Williams CM. 1965. Programmed cell death-I. Cytology of degeneration in the intersegmental muscles of the Pernyi silkmoth. J Insect Physiol. 11(2):123–133. doi: https://doi.org/10.1016/0022-1910(65)90099-5
- Lopez-Knowles E, O'Toole SA, McNeil CM, Millar EK, Qiu MR, Crea P, Daly RJ, Musgrove EA, Sutherland RL. 2010. PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality. Int J Cancer. 126(5):1121–1131. doi: https://doi.org/10.1002/ijc.24831
- Lyu J, Song H, Tian Z, Miao Y, Ren G, Guo W. 2016. Predictive value of pAKT/PTEN expression in oral squamous cell carcinoma treated with cetuximab-based chemotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 121(1):67–72. doi: https://doi.org/10.1016/j.oooo.2015.09.002
- Manning BD, Cantley LC. 2007. AKT/PKB signaling: navigating downstream. Cell. 129(7):1261–1274. doi: https://doi.org/10.1016/j.cell.2007.06.009
- Mao L, Hong WK. 2004. Papadimitrakopoulou VA: Focus on head and neck cancer. Cancer Cell. 5:311–316. doi: https://doi.org/10.1016/S1535-6108(04)00090-X
- Massano J, Regateiro FS, Januário G, Ferreira A. 2006. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 102(1):67–76. doi: https://doi.org/10.1016/j.tripleo.2005.07.038
- Mehrotra R, Gupta A, Singh M, Ibrahim R. 2006. Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer. 5:11. doi: https://doi.org/10.1186/1476-4598-5-11
- Nakano R. 1997. Apoptosis: gene-directed cell death. An Overview. Horm. Res. 48(Suppl.3):2–4. doi: https://doi.org/10.1159/000191292
- Naruse T, Kawasaki G, Yanamoto S, Mizuno A, Umeda M. 2011. Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway. Anticancer Res. 31:4429–4437.
- Oltvai ZN, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:609–619. doi: https://doi.org/10.1016/0092-8674(93)90509-O
- Pérez-Tenorio G, Stål O. 2002. Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients. Br J Cancer. 86(4):540–545. doi: https://doi.org/10.1038/sj.bjc.6600126
- Rahmani A, Alzohairy M, Khadri H, Mandal AK, Rizvi MA. 2012. Expressional evaluation of vascular endothelial growth factor (VEGF) protein in urinary bladder carcinoma patients exposed to cigarette smoke. Int J ClinExpPathol. 5:195–202.
- Rahmani AH, Babiker AY, AlWanian WM, Elsiddig SA, Faragalla HE, Aly SM. 2015. Association of cytokeratin and vimentin protein in the genesis of transitional cell carcinoma of urinary bladder patients. Dis Markers. 2015:204759. doi: https://doi.org/10.1155/2015/204759
- Sambandam Y, Sakamuri S, Balasubramanian S, Haque A. 2016. RANK ligand modulation of autophagy in oral squamous cell carcinoma tumor cells. J Cell Biochem. 117(1):118–125. doi: https://doi.org/10.1002/jcb.25255
- Singhal A, Hadi R, Chaturvedi A, Sharma ID, Misra S, Husain N. 2016. Vascular endothelial growth factor expression in oral cancer and its role as a predictive marker: a prospective study. Saudi Surg J. 4(2):52–56. doi: https://doi.org/10.4103/2320-3846.183673
- Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, et al. 2011. The mutational landscape of head and neck squamous cell carcinoma. Science. 6046:1157–1160. doi: https://doi.org/10.1126/science.1208130
- Strasser A, O'Connor L, Dixit VM. 2000. Apoptosis signaling. Annu Rev Biochem. 69:217–245. doi: https://doi.org/10.1146/annurev.biochem.69.1.217
- Thompson CB. 1995. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456–1462. doi: https://doi.org/10.1126/science.7878464
- Toulany M, Maier J, Iida M, Rebholz S, Holler M, Grottke A, Jüker M, Wheeler DL, Rothbauer U, Rodemann HP. 2017. Akt1 and Akt3 but not Akt2 through interaction with DNA-PKcs stimulate proliferation and post-irradiation cell survival of K-RAS-mutated cancer cells. Cell Death Discov. 3:170722017. doi: https://doi.org/10.1038/cddiscovery.2017.72
- Tsai HL, Yang IP, Lin CH, Chai CY, Huang YH, Chen CF, Hou MF, Kuo CH, Juo SH, Wang JY. 2013. Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection. Int J Colorectal Dis. 28:415–424. doi: https://doi.org/10.1007/s00384-012-1570-z
- Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2:489–501. doi: https://doi.org/10.1038/nrc839
- Watanabe I, Toyoda M, Okuda J, Tenjo T, Tanaka K, Yamamoto T, Kawasaki H, Sugiyama T, Kawarada Y, Tanigawa N. 1999. Detection of apoptotic cells in human colorectal cancer by Two different in situ methods: antibody against single-stranded DNA and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick End-labeling (TUNEL) methods. Jpn J Cancer Res. 90(2):188–193. doi: https://doi.org/10.1111/j.1349-7006.1999.tb00732.x
- Yang E, Korsmeyer SJ. 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 88:386–401. doi: https://doi.org/10.1182/blood.V88.2.386.bloodjournal882386
- Yavari K. 2018. Anti-angiogenesis therapy of cancer cells using 153Sm-Bevasesomab. Emerg Sci J. 2(3):130–139. doi: https://doi.org/10.28991/esj-2018-01136
- Yuan TL, Cantley LC. 2008. PI3K pathway alterations in cancer: variations on a theme. Oncogene. 27:5497–5510. doi: https://doi.org/10.1038/onc.2008.245
- Zare H. 2019. Effects of Salvia Officinalis Extract on the breast cancer cell Line. SciMedicine Journal. 1:25–29. doi: https://doi.org/10.28991/SciMedJ-2019-0101-4
- Zhang H, Peng W, Zhang Y. 2014 Jun. Detection of cell apoptosis in pelvic lymph nodes of patients with cervical cancer after neoadjuvant chemotherapy. J Int Med Res. 42(3):641–650. doi: https://doi.org/10.1177/0300060513506328